Splenic Abscess: A Single Institution Study and Review of the Literature.
10.3349/ymj.2011.52.2.288
- Author:
Won Suk LEE
1
;
Sang Tae CHOI
;
Keon Kuk KIM
Author Information
1. Department of Surgery, Gachon University of Medicine and Science, Gil Hospital, Incheon, Korea. kimkk@gilhospital.com
- Publication Type:Original Article ; Review
- Keywords:
Abscess;
infection;
spleen
- MeSH:
Abscess/diagnosis/drug therapy/microbiology/surgery/*therapy;
Adult;
Aged;
Anti-Bacterial Agents/therapeutic use;
Drainage;
Female;
Humans;
Klebsiella Infections/diagnosis/drug therapy/microbiology/surgery;
Klebsiella pneumoniae;
Male;
Middle Aged;
Splenectomy;
Splenic Diseases/diagnosis/drug therapy/*microbiology/surgery;
Streptococcal Infections/diagnosis/drug therapy/microbiology/surgery;
Treatment Outcome;
Viridans Streptococci;
Young Adult
- From:Yonsei Medical Journal
2011;52(2):288-292
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: The aim of this study was to review our experience with splenic abscesses, with respect to the relevant aspects of splenic abscesses and treatment outcomes. MATERIALS AND METHODS: We reviewed the cases of 18 patients who had splenic abscesses and who were treated at our hospital from November 1993 to December 2008. RESULTS: The most common symptom at presentation was abdominal pain in 12 patients (66.7%). The median duration from symptom onset until establishment of a diagnosis was 22 days. Streptococcus viridians was the most common pathogen (27.8%), follow by Klebsiella pneumoniae (22.2%). The mortality rate during the inpatient period and the previous 90 days was 16.6%. Three of four patients with Klebsiella pneumoniae showed a single abscess pocket. Four patients (22.2%) underwent percutaneous drainage, eight (44.5%) recieved antibiotic treatment only and six (33.3%) underwent splenectomy. CONCLUSION: There is no gold standard for treating splenic abscesses. Treatment should be customized for each patient.
